Shilpa Gupta, Jens Bedke, Michiel S. Van Der Heijden, Begoña P. Valderrama, Eiji Kikuchi, Jeannie Hoffman-Censits, Gopa Iyer, Christof Vulsteke, Steffen Rausch, Se Hoon Park, Alexandra Drakaki, Waddah Arafat, Umang Swami, Ignacio Duran, Jian-Ri Li, Blanca Homet Moreno, Jasmine Lichfield, Xuesong Yu, Yi-Tsung Lu, Thomas Powles. "Characterization of patients (pts) responding to enfortumab vedotin plus pembrolizumab (EV+P): Exploratory analysis from the phase 3 EV-302 trial of EV+P vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.746